Post- Surgery Recovery: Nerve Blocks w/ Sedation vs. Nerve Block w/ Either Sedation/Gen. Anesthesia

September 18, 2019 updated by: Hospital for Special Surgery, New York

Patient Recovery After Orthopedic Surgery Under Nerve Blocks With Sedation in Foot and Ankle Patients (FA) and Nerve Block With Either Sedation or General Anesthesia (GA) in Total Shoulder Arthroplasty (TSA) Patients. A Pilot Study

Nausea after surgery may negatively influence patient satisfaction, may delay discharge, and cause unexpected hospital admissions. The trend toward ambulatory surgery has increased the focus on postoperative nausea, but published evidence is not based on standardized criteria for assessment. Therefore, the results for postoperative nausea are very diverse, especially reports on nausea incidence after regional anesthesia, i.e. spinal anesthesia. When peripheral nerve blocks have been applied for postoperative pain control, they significantly reduce postoperative pain, opioid consumption and side effects; patients receiving general anesthesia (GA) and nerve blocks are thought likely to have less nausea than patients receiving GA alone. This study is a pilot study looking at the incidence and intensity of nausea after orthopedic surgery under nerve blocks in foot and ankle (FA) patients and under nerve blocks with either sedation or GA in total shoulder arthroplasty (TSA) patients. The results of this study will help power a future randomized controlled trial, comparing the incidence and intensity of nausea in FA patients receiving GA through laryngeal mask airway (LMA) versus spinal anesthesia.

Study Overview

Status

Completed

Conditions

Detailed Description

Nausea after surgery may negatively influence patient satisfaction, may delay discharge, and cause unexpected hospital admissions. The trend toward ambulatory surgery has increased the focus on postoperative nausea, but published evidence is not based on standardized criteria for assessment. Therefore, the results for postoperative nausea are very diverse, especially reports on nausea incidence after regional anesthesia, i.e. spinal anesthesia. This is due to varying data sources, such as nurse notes and/or patient reports, and a lack of a consistent antiemetic and pain medication protocol. The results of this study will help power a future randomized controlled trial, comparing the incidence and intensity of nausea in FA patients receiving GA through laryngeal mask airway (LMA) versus spinal anesthesia.

When peripheral nerve blocks have been applied for postoperative pain control, they significantly reduce postoperative pain, opioid consumption and side effects; patients receiving GA and nerve blocks are thought likely to have less nausea than patients receiving GA alone, due a reduction in pain leading to reduction in need for emetogenic opioids.

This study is a pilot study looking at the incidence and intensity of nausea after orthopedic surgery under nerve blocks in foot and ankle (FA) patients and under nerve blocks with either sedation or GA in total shoulder arthroplasty (TSA) patients. At the author's institution, TSA is commonly performed with a brachial plexus block and either GA or intravenous sedation. TSA patients represent a model system for the effect of GA on nausea among patients receiving nerve blocks.

Study Type

Observational

Enrollment (Actual)

55

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10021
        • Hospital for Special Surgery, New York

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients undergoing elective orthopedic surgery for foot and ankle or total shoulder replacement that are within the age limit and meet eligibility criteria.

Description

Inclusion Criteria:

  • Elective surgery
  • Age 18-99
  • Patients who are capable to provide informed consent and answer questions in English,
  • For FA patients: Planned neuraxial anesthesia + nerve block for postsurgical analgesia,
  • For TSA patients: Planned brachial plexus nerve block + either general anesthesia or IV sedation.

Exclusion Criteria:

  • Incapable to provide informed consent
  • Contraindications for regional or LMA anesthesia (anticoagulation, infection at injection site)
  • Anticipated difficult airway
  • Body mass index>35
  • Anticipated surgical procedure time less than 1 hour or more than 4 hours,
  • History of severe postoperative nausea and/or vomiting
  • American Society of Anesthesiologists physical status classification >3
  • Neuropathy
  • Pregnant or nursing women
  • Chronic opioid use (daily use of opioids one month prior to surgery/ patients requiring chronic pain interventions)
  • Prone position planned for surgery
  • Obstructive sleep apnea
  • Known allergy/sensitivity to any study medications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
FA patients under popliteal block + spinal + sedation
Foot and ankle patients under popliteal block+ spinal+ sedation
TSA patients under brachial plexus block + general (LMA)
Total shoulder arthroscopy patients under brachial plexus block + general (LMA)
TSA patients under brachial plexus block + sedation
Total shoulder arthroplasty patients under brachial plexus block + sedation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants With Nausea 1 Hour After Post-anesthesia Care Unit (PACU) Admission
Time Frame: 1 hour after surgery
Yes/no response to whether patient had nausea in the PACU 1 hour after admission. If yes, investigators will seek out intensity
1 hour after surgery
Number of Participants With Nausea
Time Frame: Average 2 hours after surgery (at discharge from the recovery room after surgery)
Yes/no question. If yes, the investigators will then seek intensity of nausea.
Average 2 hours after surgery (at discharge from the recovery room after surgery)
Intensity of Nausea
Time Frame: 1 hour after surgery
On an 11 grade Likert scale (0=no nausea, 10=worst possible nausea)
1 hour after surgery
Intensity of Nausea
Time Frame: 2 hours after surgery
On a 11 grade Likert scale (0=no nausea, 10=worst possible nausea)
2 hours after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Antiemetic Consumption
Time Frame: Duration of stay in recovery room after surgery (average 2 hours)
Yes/no question if antiemetic consumption occured.
Duration of stay in recovery room after surgery (average 2 hours)
Number of Participants With Emesis
Time Frame: 1 hour after surgery
Yes/no question. If yes, the investigators will then seek intensity of emesis
1 hour after surgery
Number of Participants With Emesis
Time Frame: Average 2 hours after surgery (at discharge from the recovery room after surgery)
Yes/no question. If yes, the investigators will then seek intensity of emesis
Average 2 hours after surgery (at discharge from the recovery room after surgery)
Number of Participants Satisfied With Anesthesia
Time Frame: PACU before discharge, an average of 2 hours
Lowest satisfaction score on a 11 grade Likert scale (0=no satisfaction, 10=maximal satisfaction).
PACU before discharge, an average of 2 hours
Patients Receiving Opioids in the PACU
Time Frame: PACU stay before discharge (average 2 hours)
Yes/no for patients that were given opioids for pain management in the PACU. If opioids were consumed, the oral morphine equivalents for the patients taking opioids was totaled.
PACU stay before discharge (average 2 hours)
Opioid Dose Among Patients Receiving Opioids in the PACU
Time Frame: Duration of PACU stay (Average 2 hours)
Total opioid dose taken by patients who took any opioids in the PACU, measured in oral morphine equivalents (mg OME)
Duration of PACU stay (Average 2 hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2015

Primary Completion (Actual)

April 1, 2016

Study Completion (Actual)

April 1, 2016

Study Registration Dates

First Submitted

November 4, 2015

First Submitted That Met QC Criteria

November 9, 2015

First Posted (Estimate)

November 11, 2015

Study Record Updates

Last Update Posted (Actual)

October 2, 2019

Last Update Submitted That Met QC Criteria

September 18, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2015-397

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nausea

Subscribe